New Jersey § 24:6i-47

§ 24:6i-47.

Medical Cannabis Provisions. Nothing in P.L.2021, c. 16 ( C.24:6I-31 et al.) shall be construed: a. to limit any privileges or rights of a registered qualifying patient, designated

caregiver, institutional caregiver, or alternative treatment center as provided in

the “Jake Honig Compassionate Use Medical Cannabis Act,” P.L.2009, c. 307 ( C.24:6I-1 et al.), or P.L.2015, c. 158 ( C.18A:40-12.22 et al.) concerning the use of medical cannabis and medical cannabis products; b. to authorize an alternative treatment center to provide cannabis items to or on

behalf of a person who is not a registered qualifying patient, unless that alternative

treatment center is deemed to be licensed to engage in the retail sale of cannabis

items pursuant to section 7 of P.L.2009, c. 307 ( C.24:6I-7 ) and issued a license by the commission following receipt of a municipality's written

approval for a cannabis retailer pursuant to subparagraph (a) of paragraph (3) of

subsection a. of section 33 of P.L.2021, c. 16 ( C.24:6I-46 ), or otherwise has applied for a license, and been approved and issued a license

by the commission pursuant to P.L.2021, c. 16 ( C.24:6I-31 et al.) to simultaneously operate as a cannabis retailer, and the alternative treatment

center has certified to the commission pursuant to paragraph (3) of subsection a.

of that section 33 ( C.24:6I-46 ), that it has sufficient quantities of medical cannabis and medical cannabis products

available to meet the reasonably anticipated needs of registered qualifying patients,

and the commission has accepted the alternative treatment center's certification; c. to authorize an alternative treatment center to purchase or acquire cannabis or

cannabis items in a manner or from a source not permitted under the “Jake Honig Compassionate

Use Medical Cannabis Act,” P.L.2009, c. 307 ( C.24:6I-1 et al.) or P.L.2015, c. 158 ( C.18A:40-12.22 et al.), unless that alternative treatment center is deemed to be a licensed cannabis

establishment or delivery service pursuant to section 7 of P.L.2009, c. 307 ( C.24:6I-7 ) and issued a license by the commission following receipt of a municipality's written

approval for the cannabis establishment or delivery service pursuant to subparagraph

(a) of paragraph (3) of subsection a. of section 33 of P.L.2021, c. 16 ( C.24:6I-46 ), or otherwise has applied for a license, and been approved and issued a license

by the commission pursuant to P.L.2021, c. 16 ( C.24:6I-31 et al.) to simultaneously operate as a cannabis establishment or delivery service,

and the alternative treatment center has certified to the commission pursuant to paragraph

(3) of subsection a. of that section 33 ( C.24:6I-46 ), that it has sufficient quantities of medical cannabis and, if applicable, medical

cannabis products available to meet the reasonably anticipated needs of registered

qualifying patients, and the commission has accepted the alternative treatment center's

certification; d. to authorize an alternative treatment center issued a permit under section 7 of P.L.2009, c. 307 ( C.24:6I-7 ) to operate on the same premises as a cannabis license holder or applicant for a

license, unless that alternative treatment center is deemed to be a licensed cannabis

establishment or delivery service pursuant to section 7 of P.L.2009, c. 307 ( C.24:6I-7 ) and issued a license by the commission following receipt of a municipality's written

approval for the cannabis establishment or delivery service pursuant to subparagraph

(a) of paragraph (3) of subsection a. of section 33 of P.L.2021, c. 16 ( C.24:6I-46 ), or otherwise has applied for a license, and been approved and issued a license

by the commission pursuant to P.L.2021, c. 16 ( C.24:6I-31 et al.) to simultaneously operate as a cannabis establishment or delivery service,

and the alternative treatment center has certified to the commission pursuant to paragraph

(3) of subsection a. of that section 33 ( C.24:6I-46 ), that it has sufficient quantities of medical cannabis and, if applicable, medical

cannabis products available to meet the reasonably anticipated needs of registered

qualifying patients, and the commission has accepted the alternative treatment center's

certification.